Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers.
J Med Chem
; 59(14): 6671-89, 2016 07 28.
Article
in En
| MEDLINE
| ID: mdl-27433829
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzimidazoles
/
Carcinoma, Non-Small-Cell Lung
/
Protein Kinase Inhibitors
/
Drug Discovery
/
ErbB Receptors
/
Lung Neoplasms
/
Nicotine
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2016
Document type:
Article
Affiliation country:
Country of publication: